Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RCLF | COMMON STOCK | Other | +23.3K | 23.3K | Sep 11, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RCLF | INCENTIVE STOCK OPTION | Other | +569K | 569K | Sep 11, 2023 | COMMON STOCK | 569K | $1.03 | Direct | F1, F3, F4 | |||
transaction | RCLF | INCENTIVE STOCK OPTION | Other | +233K | 233K | Sep 11, 2023 | COMMON STOCK | 233K | $2.17 | Direct | F1, F3, F4 | |||
transaction | RCLF | INCENTIVE STOCK OPTION | Other | +24.2K | 24.2K | Sep 11, 2023 | COMMON STOCK | 24.2K | $4.95 | Direct | F1, F4, F5 | |||
transaction | RCLF | INCENTIVE STOCK OPTION | Other | +7.27K | 7.27K | Sep 11, 2023 | COMMON STOCK | 7.27K | $4.54 | Direct | F1, F4, F6 |
Id | Content |
---|---|
F1 | On September 11, 2023, Spectral AI, Inc., a Delaware corporation formerly known as Rosecliff Acquisition Corp. I (the "Issuer") and Spectral MD Holdings Ltd ("Spectral") consummated the business combination (the "Business Combination") pursuant to that certain business combination agreement, dated April 11, 2023 (as amended, the "Business Combination Agreement"). In connection with the closing of the Business Combination (the "Closing"), each 10.31 shares of common stock of Spectral outstanding immediately prior to the Closing were exchanged for one share of common stock of the Issuer, par value $0.0001 (the "Common Stock"). |
F2 | The Reporting Person received these shares of Common Stock in connection with the Closing for no additional consideration. |
F3 | These options are vested and exercisable. |
F4 | The Reporting Person received these securities in connection with the Closing, for no additional consideration, with each option exercisable for one share of the Issuer's Common Stock once such option fully vests. |
F5 | These options vest and become exercisable as follows: 33% of the stock options vested on 2/3/2023; 33% vest on 2/3/2024; and the remainder vest on 2/3/2025. |
F6 | These options vest and become exercisable as follows: 33% of the stock options vest on 4/13/2024; 33% vest on 4/13/2025; and the remainder vest on 4/13/2026. |